AVILA THERAPEUTICS INC — Form D/A
AVILA THERAPEUTICS INC of WALTHAM, MA, a company, filed a Form D amendment with the SEC on 2010-07-06. The offering totals $30.0M, of which $22.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2010-07-06
- Form: D/A
- Accession: 0001433874-10-000002
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $30.0M
- Amount sold: $22.5M
- Remaining: $7.5M
- Investors: 9
- Date of first sale: 2009-07-16
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-117636
Issuer
- Name: AVILA THERAPEUTICS INC
- CIK: 0001433874
- Entity type: Corporation
- Jurisdiction: DE
- Incorporated: 2006
- Address: 100 BEAVER STREET, WALTHAM, MA, 02453
- Phone: 781-891-0086
Officers, directors & promoters (19)
| Name | Role | Location |
|---|
| Michael F Bigham | Director | London, X0 |
| Bruce F Booth | Director | Waltham, MA |
| KATRINE BOSLEY | Director | CAMBRIDGE, MA |
| Roy R Lobb | Director | Wellesley, MA |
| Daniel R Lynch | Director | Waltham, MA |
| Amir R Nashat | Director | Waltham, MA |
| Raj R Parekh | Director | Waltham, MA |
| Vicki R Sato | Director | Waltham, MA |
| Henry R Skinner | Director | Waltham, MA |
| Michael F Bigham | Executive Officer | London, X0 |
| KATRINE BOSLEY | Executive Officer | CAMBRIDGE, MA |
| Roy R Lobb | Executive Officer | Wellesley, MA |
| Bruce Booth | Director | Cambridge, MA |
| Raj Parekh | Director | Waltham, MA |
| Daniel Lynch | Director | Greenfield, IN |
| Daniel Lynch | Executive Officer | Greenfield, IN |
| AMIR NASHAT | Director | San Diego, CA |
| Vicki Sato | Director | San Francisco, CA |
| HENRY SKINNER | Director | SAN DIEGO, CA |
Other filings by this issuer (2)
More